Discovery of Potential Novel Lipid Biomarkers for Heart Failure Based on UPLC‐QTRAP‐MS
Rapid Communications in Mass Spectrometry · 30.07.2026 · 40 (14)
DOI: 10.1002/rcm.70092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, online erschienen am 22.04.2026. Verfasst von Hui Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Heart Failure, Lipids, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 31 Literaturangaben. Gefördert von: 2022 Beijing major epidemic prevention and control key specialty intensive care medical construction project.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF), a leading cause of global morbidity and mortality, is associated with dysregulated lipid metabolism and a lack of reliable diagnostic biomarkers. To identify potential biomarkers, we performed targeted analysis using Scheduled MRM on a Sciex QTRAP 5500 system to profile plasma metabolites in HF patients. First, we compared plasma lipidomes between 38 HF patients and 28 non‐disease group (NO) using ultra‐high‐performance liquid chromatography–mass spectrometry (UHPLC‐MS). Candidate lipids were then identified through t ‐tests, multivariate analyses, and receiver operating characteristic (ROC) curve evaluations. The results revealed 43 significantly altered lipids between HF patients and non‐disease group. ROC analysis identified 14 lipids with area under the curve (AUC) values > 0.95, demonstrating high diagnostic potential. These were further analyzed using binary logistic regression in MetaboAnalyst 5.0. This study provides clinicians with an objective method for early HF detection while advancing the understanding of HF pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Förderung
- 2022 Beijing major epidemic prevention and control key specialty intensive care medical construction project
Zitieren
APA
Zhang, H., Zhao, G., Chen, W., & Li, H. (2026). Discovery of Potential Novel Lipid Biomarkers for Heart Failure Based on UPLC‐QTRAP‐MS. Rapid Communications in Mass Spectrometry, 40(14). https://doi.org/10.1002/rcm.70092
Vancouver
Zhang H, Zhao G, Chen W, Li H. Discovery of Potential Novel Lipid Biomarkers for Heart Failure Based on UPLC‐QTRAP‐MS. Rapid Communications in Mass Spectrometry. 2026;40(14). doi:10.1002/rcm.70092
BibTeX
@article{Zhang2026,
author = {Zhang, Hui and Zhao, Guomin and Chen, Wei and Li, Hongliang},
title = {Discovery of Potential Novel Lipid Biomarkers for Heart Failure Based on UPLC‐QTRAP‐MS},
journal = {Rapid Communications in Mass Spectrometry},
year = {2026},
volume = {40},
number = {14},
doi = {10.1002/rcm.70092}
}
EUVIMED